Race Oncology Future Growth
Future criteria checks 0/6
Race Oncology's revenue and earnings are forecast to decline at 2.4% and 14.1% per annum respectively while EPS is expected to decline by 11.7% per annum.
Key information
-14.1%
Earnings growth rate
-11.7%
EPS growth rate
Biotechs earnings growth | 15.9% |
Revenue growth rate | -2.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Jun 2024 |
Recent future growth updates
No updates
Recent updates
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully
May 10We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate
Jan 23Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation
Oct 05Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth
Jun 20We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow
Feb 17Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation
Oct 14Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation
Apr 01We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely
Apr 05What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?
Mar 01How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?
Jan 07Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 5 | -16 | -15 | -15 | 1 |
6/30/2025 | 4 | -13 | -13 | -13 | 1 |
6/30/2024 | 4 | -12 | -11 | -11 | 1 |
12/31/2023 | 6 | -11 | -13 | -13 | N/A |
9/30/2023 | 4 | -11 | -12 | -12 | N/A |
6/30/2023 | 3 | -10 | -11 | -11 | N/A |
3/31/2023 | 2 | -10 | -10 | -10 | N/A |
12/31/2022 | 1 | -11 | -9 | -9 | N/A |
9/30/2022 | 1 | -11 | -8 | -8 | N/A |
6/30/2022 | 1 | -11 | -6 | -6 | N/A |
3/31/2022 | 1 | -10 | -6 | -6 | N/A |
12/31/2021 | 1 | -9 | -6 | -6 | N/A |
9/30/2021 | 1 | -8 | -5 | -5 | N/A |
6/30/2021 | 0 | -6 | -5 | -5 | N/A |
3/31/2021 | 0 | -5 | -4 | -4 | N/A |
12/31/2020 | 0 | -4 | -3 | -3 | N/A |
9/30/2020 | 0 | -4 | -3 | -3 | N/A |
6/30/2020 | 0 | -4 | -2 | -2 | N/A |
3/31/2020 | 0 | -3 | -2 | -2 | N/A |
12/31/2019 | 0 | -3 | -2 | -2 | N/A |
9/30/2019 | 0 | -3 | -2 | -2 | N/A |
6/30/2019 | 0 | -4 | -3 | -3 | N/A |
3/31/2019 | 0 | -4 | -3 | -3 | N/A |
12/31/2018 | 0 | -5 | -3 | -3 | N/A |
9/30/2018 | 0 | -6 | -3 | -3 | N/A |
6/30/2018 | 0 | -6 | -4 | -4 | N/A |
3/31/2018 | 0 | -6 | -4 | -4 | N/A |
12/31/2017 | 0 | -6 | -4 | -4 | N/A |
9/30/2017 | 0 | -5 | N/A | -3 | N/A |
6/30/2017 | N/A | -4 | N/A | -2 | N/A |
3/31/2017 | N/A | -3 | N/A | -2 | N/A |
12/31/2016 | N/A | -2 | N/A | -1 | N/A |
9/30/2016 | N/A | -1 | N/A | -1 | N/A |
6/30/2016 | N/A | 0 | N/A | 0 | N/A |
3/31/2016 | N/A | 0 | N/A | 0 | N/A |
12/31/2015 | N/A | 0 | N/A | 0 | N/A |
9/30/2015 | N/A | 0 | N/A | 0 | N/A |
6/30/2015 | N/A | 0 | N/A | 0 | N/A |
6/30/2014 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RAC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RAC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RAC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RAC's revenue is expected to decline over the next 3 years (-2.4% per year).
High Growth Revenue: RAC's revenue is forecast to decline over the next 3 years (-2.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RAC's Return on Equity is forecast to be high in 3 years time